Foundations and innovation in commercial planning for a rare disease launch
With increased competition, price pressures, and customer expectations, preparing for a rare disease drug launch is more challenging than ever before. In this presentation Herspiegel with sharing our experience with rare disease product launches, including:
- Identify critical commercial planning activities to accelerate forecast attainment
- Assess key technology tools that can create greater visibility and responsiveness to market dynamics
- Hear real-world examples of common roadblocks and mitigation strategies to avoid delaying your launch
